ViiV’s Rukobia wins EU authorisation to treat multidrug-resistant HIV
10 Feb 2021 //
PHARMATIMES
ViiV`s HIV drug Rukobia gets EC marketing authorisation
09 Feb 2021 //
PHARMAFILE
GSK snags FDA nod for Rukobia in multidrug-resistant HIV
06 Jul 2020 //
FIERCE PHARMA
ViiV Healthcare Announces US FDA Approval for Rukobia (fostemsavir)
02 Jul 2020 //
BUSINESSWIRE
ViiV Healthcare submits regulatory application to the EMA for fostemsavir
11 Jan 2020 //
BUSINESS WIRE